116 related articles for article (PubMed ID: 28429344)
1. Up-regulation of microRNA-367 promotes liver steatosis through repressing TBL1 in obese mice.
Li DD; Liu Y; Xue L; Su DY; Pang WY
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1598-1603. PubMed ID: 28429344
[TBL] [Abstract][Full Text] [Related]
2. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
Zhang T; Zhao X; Steer CJ; Yan G; Song G
Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR.
Nie H; Song C; Wang D; Cui S; Ren T; Cao Z; Liu Q; Chen Z; Chen X; Zhou Y
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3087-3094. PubMed ID: 28951211
[TBL] [Abstract][Full Text] [Related]
5. Obesity-induced upregulation of miR-361-5p promotes hepatosteatosis through targeting Sirt1.
Zhang Z; Liu X; Xu H; Feng X; Lin Y; Huang Y; Peng Y; Gu M
Metabolism; 2018 Nov; 88():31-39. PubMed ID: 30309516
[TBL] [Abstract][Full Text] [Related]
6. Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.
Kulozik P; Jones A; Mattijssen F; Rose AJ; Reimann A; Strzoda D; Kleinsorg S; Raupp C; Kleinschmidt J; Müller-Decker K; Wahli W; Sticht C; Gretz N; von Loeffelholz C; Stockmann M; Pfeiffer A; Stöhr S; Dallinga-Thie GM; Nawroth PP; Diaz MB; Herzig S
Cell Metab; 2011 Apr; 13(4):389-400. PubMed ID: 21459324
[TBL] [Abstract][Full Text] [Related]
7. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1.
Zhang M; Sun W; Zhou M; Tang Y
Sci Rep; 2017 Nov; 7(1):14493. PubMed ID: 29101357
[TBL] [Abstract][Full Text] [Related]
11. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
12. miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes.
Wang JJ; Zhang YT; Tseng YJ; Zhang J
Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):360-365. PubMed ID: 31126802
[TBL] [Abstract][Full Text] [Related]
13. Biochanin A improves hepatic steatosis and insulin resistance by regulating the hepatic lipid and glucose metabolic pathways in diet-induced obese mice.
Park HS; Hur HJ; Kim SH; Park SJ; Hong MJ; Sung MJ; Kwon DY; Kim MS
Mol Nutr Food Res; 2016 Sep; 60(9):1944-55. PubMed ID: 27145114
[TBL] [Abstract][Full Text] [Related]
14. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
15. An Endoplasmic Reticulum Stress-MicroRNA-26a Feedback Circuit in NAFLD.
Xu H; Tian Y; Tang D; Zou S; Liu G; Song J; Zhang G; Du X; Huang W; He B; Lin W; Jin L; Huang W; Yang J; Fu X
Hepatology; 2021 Apr; 73(4):1327-1345. PubMed ID: 32567701
[TBL] [Abstract][Full Text] [Related]
16. Decreased MiR-155 Level in the Peripheral Blood of Non-Alcoholic Fatty Liver Disease Patients may Serve as a Biomarker and may Influence LXR Activity.
Wang L; Zhang N; Wang Z; Ai DM; Cao ZY; Pan HP
Cell Physiol Biochem; 2016; 39(6):2239-2248. PubMed ID: 27832630
[TBL] [Abstract][Full Text] [Related]
17. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1.
Wang Y; Zhu K; Yu W; Wang H; Liu L; Wu Q; Li S; Guo J
Biochem Biophys Res Commun; 2017 Nov; 493(1):227-232. PubMed ID: 28899784
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29a Suppresses CD36 to Ameliorate High Fat Diet-Induced Steatohepatitis and Liver Fibrosis in Mice.
Lin HY; Wang FS; Yang YL; Huang YH
Cells; 2019 Oct; 8(10):. PubMed ID: 31652636
[TBL] [Abstract][Full Text] [Related]
19. Suppression of miR-30a-3p Attenuates Hepatic Steatosis in Non-alcoholic Fatty Liver Disease.
Wang DR; Wang B; Yang M; Liu ZL; Sun J; Wang Y; Sun H; Xie LJ
Biochem Genet; 2020 Oct; 58(5):691-704. PubMed ID: 32419060
[TBL] [Abstract][Full Text] [Related]
20. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]